JNS107

N/A

Report date: 2024/12/13 14:54:12
NME

Base Information

Drug NameJNS107
Drug Alias NameJNS107JNS-107
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAngiogenesis inhibitorsNAD-dependent deacetylase sirtuin 1 stimulants
TargetsNAD-dependent deacetylase sirtuin 1
Therapy Area/IndicationsMELAS Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesJupiter Neurosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesJupiter Neurosciences Inc
Inactive CompaniesN/A
Active IndicationsMELAS Syndrome
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A